Moderna CEO Stephane Bancel believes the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors. Speaking with Romaine Bostick on "Bloomberg The Close," Bancel also says the recent data leak for the cancer vaccine candidate did not come from either Moderna or Merck. (Source: Bloomberg)
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.